California 2017-2018 Regular Session

California Assembly Bill AB2653

Introduced
2/15/18  
Introduced
2/15/18  
Refer
3/22/18  
Refer
3/22/18  
Report Pass
3/23/18  
Refer
4/2/18  

Caption

Health care coverage: prescriptions.

Impact

The bill mandates that starting January 1, 2019, health care plans covering outpatient prescription drug benefits must include coverage for these two medications, which are primarily used to treat alcohol and opioid dependence. This aligns with California's broader health policy goals of improving treatment options and ensuring that individuals have access to necessary medications to aid in recovery processes. Since the bill imposes criminal penalties for non-compliance, it also establishes a level of regulatory oversight for health care providers and insurers.

Summary

Assembly Bill 2653, introduced by Assembly Member Travis Allen, aims to amend the Health and Safety Code and the Insurance Code to require health care service plans and small group health insurance policies to provide coverage for the prescription drugs naltrexone and acamprosate, specifically when prescribed by licensed professionals. This legislation is part of California's ongoing efforts to address healthcare accessibility, particularly concerning treatment options for individuals suffering from substance use disorders.

Sentiment

The general sentiment around AB 2653 appears to be positive, particularly among health advocacy groups and those focused on addiction treatment. Proponents see this bill as a significant step toward reducing barriers to treatment and promoting public health. However, concerns have been raised over how this requirement will affect insurance premiums and the logistics of integrating these mandates within existing health care frameworks. The balance between accessibility and cost remains a point of contention in legislative circles.

Contention

One notable point of contention involves the implications of creating new criminal penalties for violations of the coverage mandate. While supporters argue that this ensures compliance and accountability within health care markets, critics fear that it could lead to unintended consequences, including potential increases in healthcare costs or reduced willingness of insurers to offer comprehensive plans. Additionally, discussions around the state's responsibility to reimburse local agencies for costs incurred due to this bill have also highlighted concerns regarding fiscal impacts on public budgets.

Companion Bills

No companion bills found.

Similar Bills

CA AB2384

Medication-assisted treatment.

CA AB1288

Health care coverage: Medication-assisted treatment.

CA AB1842

Health care coverage: Medication-assisted treatment.

CA AB395

Substance use treatment providers.

CA AB1963

Medi-Cal: reimbursement: opioid addiction treatment.

TX SB1564

Relating to access to certain medication-assisted treatment.

CA AB182

Heroin and Opioid Public Education (HOPE) Act.